showed a trendP =0.09
Compared with the FLO group, the FLOT group showed a trend towards an improved median PFS (21.1 vs 12.0 months; P =0.09), however, associated with increased chemotherapy related toxicity.
Compared with the FLO group, the FLOT group showed a trend towards an improved median PFS (21.1 vs 12.0 months; P =0.09), however, associated with increased chemotherapy related toxicity.